Joincare Pharmaceutical Group Industry Co.,Ltd.’s Net Profit Rose 6.1% in First Three Quarters of 2022

Joincare Pharmaceutical Group Industry Co.,Ltd. (健康元药业集团股份有限公司) (600380.SH) reported a net profit of 2.2 billion yuan in the first three quarters of 2022, up 6.1% year-on-year.

Meanwhile, the company posted 13 billion yuan in revenue, up 9% year-on-year.

At the end of the reporting period, it had 34.7 billion yuan in total assets and 13.3 billion yuan in total liabilities, with a liability-to-asset ratio of 38.2%.